Tim Springer (Scott Eisen/Bloomberg via Getty Images)
May 27, 2021 09:43 AM EDTUpdated 10:47 AM
People
R&D

Alise Re­icin re­cruits GNF vet Pe­ter Mc­Na­ma­ra to head re­search at Tim Springer's lat­est start­up

John Carroll

Editor & Founder

Alise Re­icin has just made a key ad­di­tion to her top team at Tec­ton­ic, the new Boston up­start kick­start­ed in­to ex­is­tence by bil­lion­aire Har­vard sci­en­tist …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

Sanofi, Ope­nAI, For­ma­tion Bio de­but pa­tient re­cruit­ing tool, will use in Phase 3 mul­ti­ple scle­ro­sis stud­ies

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times